The U.S. Army is giving Madison biotech ConjuGon a $730,000 grant to keep working on a treatment for bacterial infections that haven’t been cured by antibiotics up to now.
Established in 2002 and based on UW-Madison research, ConjuGon has developed genetically engineered, harmless bacteria that have been proven successful in animal tests, said Sal Braico, chief operating officer.
Office of Strategic Communication